Advances in the Treatment of Multiple Primary Lung Cancer.
10.3779/j.issn.1009-3419.2025.102.17
- Author:
Ying XIAO
1
;
Xiaobo CHEN
1
;
Xinghe TONG
1
;
Xudong YANG
1
;
Yanlong YANG
1
;
Yunping ZHAO
1
Author Information
1. Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming 650100, China.
- Publication Type:English Abstract
- Keywords:
Ablation;
Drug therapy;
Lung neoplasms;
Multimodal therapy;
Radiation therapy;
Surgery
- MeSH:
Humans;
Lung Neoplasms/surgery*;
Immunotherapy;
Combined Modality Therapy
- From:
Chinese Journal of Lung Cancer
2025;28(6):460-466
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the incidence of multiple primary lung cancer (MPLC) has been increasing, and it cannot be ignored in clinical practice. The treatment of MPLC is still controversial, but surgical treatment is recognized as the most important treatment. However, current studies have shown that the treatment of MPLC needs to develop multimodal treatment according to different patients. This review summarizes multiple treatment method for MPLC, including surgery, ablation, chemotherapy, radiotherapy, targeted therapy, and immunotherapy in order to enhance understanding of MPLC treatment.
.
